425 related articles for article (PubMed ID: 12473595)
21. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
23. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.
Xu E; Lai M; Lŭ B; Xing X; Huang Q
Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230
[TBL] [Abstract][Full Text] [Related]
24. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
25. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
26. Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.
Ju W; Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(2):191-6. PubMed ID: 15617836
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Liu PY; Li YH; Chan SH; Lin LJ; Wu HL; Shi GY; Chen JH
Am J Cardiol; 2006 Oct; 98(8):1012-7. PubMed ID: 17027562
[TBL] [Abstract][Full Text] [Related]
28. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
Djurić T; Zivković M; Radak D; Jekić D; Radak S; Stojković L; Raicević R; Stanković A; Alavantić D
Clin Biochem; 2008 Nov; 41(16-17):1326-9. PubMed ID: 18801353
[TBL] [Abstract][Full Text] [Related]
29. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
[TBL] [Abstract][Full Text] [Related]
30. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.
Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L
Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464
[TBL] [Abstract][Full Text] [Related]
31. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D
Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769
[TBL] [Abstract][Full Text] [Related]
32. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
33. Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects.
Mora B; Bonamico M; Ferri M; Megiorni F; Osborn J; Pizzuti A; Mazzilli MC
Hum Immunol; 2005 Jun; 66(6):716-20. PubMed ID: 15993717
[TBL] [Abstract][Full Text] [Related]
34. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
39. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
[TBL] [Abstract][Full Text] [Related]
40. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
